Common stock

Superdry plc: Director/PDMR Shareholding

Retrieved on: 
Wednesday, April 10, 2024
Name, Trustee, SIP, Common stock, Customs

On 14 March 2024, the following transactions by PDMRs took place in relation to Superdry’s Share Incentive Plan (SIP).

Key Points: 
  • On 14 March 2024, the following transactions by PDMRs took place in relation to Superdry’s Share Incentive Plan (SIP).
  • The SIP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy shares in the Company of 5 pence each (Ordinary Shares), using deductions from salary in each calendar month (Partnership Shares), and receive allocations of matching free Ordinary Shares (Matching Shares).
  • Details of the number of Partnership Shares purchased by the PDMRs at a price of £0.301 per Ordinary Share, and the number of Matching Shares allocated by the SIP Trustees to the PDMRs for no consideration, are set out against their names in the table below.

Fuller, Smith & Turner PLC: Extension of Share Buyback Programme

Retrieved on: 
Wednesday, April 10, 2024
LAWS, Annual, ANY, Common stock, London Stock Exchange, Listing Rules, Security (finance)

As announced on 21 March 2024, following the repurchase of 1 million ‘A’ ordinary shares of 40p each in the Company (“Ordinary Shares”) under an arrangement with Numis Securities Limited (the “Programme”) which commenced on 16 November 2023, the Company has decided to extend the Programme and repurchase up to a further 1 million Ordinary Shares.

Key Points: 
  • As announced on 21 March 2024, following the repurchase of 1 million ‘A’ ordinary shares of 40p each in the Company (“Ordinary Shares”) under an arrangement with Numis Securities Limited (the “Programme”) which commenced on 16 November 2023, the Company has decided to extend the Programme and repurchase up to a further 1 million Ordinary Shares.
  • This is consistent with the Company’s capital allocation framework and reflects the Board’s view that the current share price continues to represent a significant discount to the Company’s underlying net asset value.
  • The Programme is expected to enhance earnings per share.
  • Any market purchase of Ordinary Shares under the Programme will be announced no later than 7:30 a.m. on the business day following the day on which the purchase occurred.

Delisting of Securities of NanoString Technologies, Inc.; Remark Holdings, Inc.; Sunworks, Inc.; Cyanotech Corporation; Sientra, Inc.; Atlantic Coastal Acquisition Corp.; Charge Enterprises, Inc.; Sagaliam Acquisition Corp.; TG Venture Acquisition Corp.;

Retrieved on: 
Monday, April 8, 2024
Common stock, NanoString Technologies, Cryptocurrency

Nasdaq also announced today that it will delist the common stock of Remark Holdings, Inc.

Key Points: 
  • Nasdaq also announced today that it will delist the common stock of Remark Holdings, Inc.
  • Remark Holdings, Inc.’s securities were suspended on February 14, 2024, and have not traded on Nasdaq since that time.
  • Cyanotech Corporation’s securities were suspended on February 20, 2024, and have not traded on Nasdaq since that time.
  • Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series .

Renalytix Announces Financing with Expected Size of up to $4 Million

Retrieved on: 
Monday, April 8, 2024
Common stock, Form, Sale, ADS, Prospectus, Fundraising, Security (finance)

Both tranches are priced at $0.75 per NASDAQ ADS ($0.375 per Ordinary Share).

Key Points: 
  • Both tranches are priced at $0.75 per NASDAQ ADS ($0.375 per Ordinary Share).
  • The aggregate total amount for both tranches, if the option is fully exercised, is expected to be up to $4 million in total financing.
  • The net proceeds of the Fundraise will be used to support commercial sales activity as the Company continues its Formal Sale Process, as previously announced.
  • The completion of the sale and purchase of the Initial Tranche Shares is expected take place no later than 11 April 2024, subject to customary closing conditions.

Eagle Shareholders Approve Merger With Star Bulk

Retrieved on: 
Friday, April 5, 2024
Common stock, Certification, Plan, Agreement, Special, Sub, Security (finance), Eagle, Debt-to-GDP ratio

STAMFORD, Conn., April 05, 2024 (GLOBE NEWSWIRE) -- Eagle Bulk Shipping Inc. (NYSE: EGLE) (“Eagle” or the “Company”) today announced that its shareholders voted in favor of (1) a proposal to approve and authorize the previously announced Agreement and Plan of Merger, dated December 11, 2023 (the “Merger Agreement”), entered into by and among Star Bulk Carriers Corp. (“Star Bulk”), Star Infinity Corp. (“Merger Sub”) and the Company and the merger contemplated thereby (the “Merger Proposal”) and (2) a proposal to authorize and approve the issuance of shares of the Company’s common stock, $0.01 par value per share (the “Common Stock”), issuable upon the potential future conversion of the Company’s 5.00% Convertible Senior Notes due 2024 in excess of the conversion share cap set forth in the Indenture, dated as of July 29, 2019, between the Company and Deutsche Bank Trust Company Americas (the “Convertible Note Share Issuance Proposal”) at its special meeting of shareholders (the “Special Meeting”) held earlier today.

Key Points: 
  • STAMFORD, Conn., April 05, 2024 (GLOBE NEWSWIRE) -- Eagle Bulk Shipping Inc. (NYSE: EGLE) (“Eagle” or the “Company”) today announced that its shareholders voted in favor of (1) a proposal to approve and authorize the previously announced Agreement and Plan of Merger, dated December 11, 2023 (the “Merger Agreement”), entered into by and among Star Bulk Carriers Corp. (“Star Bulk”), Star Infinity Corp. (“Merger Sub”) and the Company and the merger contemplated thereby (the “Merger Proposal”) and (2) a proposal to authorize and approve the issuance of shares of the Company’s common stock, $0.01 par value per share (the “Common Stock”), issuable upon the potential future conversion of the Company’s 5.00% Convertible Senior Notes due 2024 in excess of the conversion share cap set forth in the Indenture, dated as of July 29, 2019, between the Company and Deutsche Bank Trust Company Americas (the “Convertible Note Share Issuance Proposal”) at its special meeting of shareholders (the “Special Meeting”) held earlier today.
  • At the Special Meeting, approximately 65% of the Company’s outstanding shares (approximately 99% of the shares of Common Stock present at the Special Meeting) were voted in favor of the Merger Proposal and approximately 96% of the votes cast were voted in favor of the Convertible Note Share Issuance Proposal.
  • Under the terms of the Merger Agreement, at the effective time, each share of the Common Stock issued and outstanding immediately prior to the effective time (excluding Common Stock owned by Eagle, Star Bulk, Merger Sub or any of their respective direct or indirect wholly owned subsidiaries) will be cancelled in exchange for the right to receive 2.6211 shares of common stock of Star Bulk, par value $0.01 per share, and any cash payable in respect of fractional shares.
  • The Company now expects to complete the merger on or about April 9, 2024, subject to the satisfaction of the remaining closing conditions.

Semantix Announces Voluntary Delisting from the Nasdaq Global Market

Retrieved on: 
Thursday, April 4, 2024
Common stock, Security (finance), Removal, Section, OTC

SÃO PAULO, Brazil, April 04, 2024 (GLOBE NEWSWIRE) -- Semantix, Inc. (NASDAQ: STIX) (“Semantix” or the “Company”), a leading Latin American enterprise AI platform and applications provider, announced today that it has notified the Nasdaq Stock Market LLC (“Nasdaq”) of its decision to voluntarily delist its ordinary shares, par value $0.001 per share (the “Ordinary Shares”) and its warrants exercisable for one Ordinary Share at an exercise price of $11.50 (the “Warrants”) from the Nasdaq Global Market.

Key Points: 
  • SÃO PAULO, Brazil, April 04, 2024 (GLOBE NEWSWIRE) -- Semantix, Inc. (NASDAQ: STIX) (“Semantix” or the “Company”), a leading Latin American enterprise AI platform and applications provider, announced today that it has notified the Nasdaq Stock Market LLC (“Nasdaq”) of its decision to voluntarily delist its ordinary shares, par value $0.001 per share (the “Ordinary Shares”) and its warrants exercisable for one Ordinary Share at an exercise price of $11.50 (the “Warrants”) from the Nasdaq Global Market.
  • Following the delisting of Semantix’s Ordinary Shares and Warrants from trading on Nasdaq, any trading in such securities would only occur in privately negotiated sales and potentially on an over-the-counter market.
  • Semantix expects to have its Ordinary Shares and Warrants quoted on a market operated by OTC Markets Group Inc. (the “OTC”) so that a trading market may continue to exist for such securities.
  • There is no guarantee, however, that a broker will continue to make a market in Semantix’s Ordinary Shares and Warrants and that trading thereof will continue on an OTC market or otherwise.

InterDigital Announces Convertibility of 3.50% Senior Convertible Notes Due 2027

Retrieved on: 
Thursday, April 4, 2024
Common stock, Financial statement, Calendar, Research, InterDigital, IDCC, Note

WILMINGTON, Del., April 04, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, announced today that, pursuant to the terms of the Indenture governing its 3.50% Senior Convertible Notes due 2027 (the “Notes”), the Notes are convertible during its calendar quarter ending June 30, 2024.

Key Points: 
  • WILMINGTON, Del., April 04, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, announced today that, pursuant to the terms of the Indenture governing its 3.50% Senior Convertible Notes due 2027 (the “Notes”), the Notes are convertible during its calendar quarter ending June 30, 2024.
  • The current conversion rate of the Notes is 12.9041 shares of InterDigital’s Common Stock per $1,000 principal amount of the Notes.
  • At the time InterDigital issued the Notes, InterDigital entered into call spread transactions that together were designed to have the economic effect of reducing the net number of shares that will be issued in the event of conversion of the Notes by, in effect, increasing the conversion price of the Notes from InterDigital’s economic standpoint from $77.49 to $106.35.
  • Refer to Footnote 10 of the Financial Statements from InterDigital’s Form 10-K for the year ended December 31, 2023 for more information.

Vemanti Gains Hospitality Digital Transformation Capabilities Across SE Asia with Acquisition of VinHMS

Retrieved on: 
Wednesday, April 3, 2024
Online, Common stock, Organization, Growth, Agoda, COVID-19, Siteminder, Travel, Vingroup, Booking.com, Artificial intelligence, Acquisition, City, Tourism, GDP, Development, Traveloka, Machine learning, USD, Management

IRVINE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Vemanti Group, Inc. (“Vemanti” or the “Company”) (OTCQB: VMNT) today announced the successful acquisition of VinHMS Pte.

Key Points: 
  • IRVINE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Vemanti Group, Inc. (“Vemanti” or the “Company”) (OTCQB: VMNT) today announced the successful acquisition of VinHMS Pte.
  • Ltd. (“VinHMS”), a Singapore-based technology solutions provider specializing in digital transformation for the hospitality industry across Southeast Asia.
  • In addition to its flagship hospitality management solution, CiHMS, VinHMS offers a suite of products, including asset management (CiAMS), theme park management (CiTMS), and a digital transformation solution for small hotels (CiTravel).
  • The company has established itself as a leader in hospitality digital transformation with a proven track record of successful implementations for numerous hotels.

Palisade Bio Announces 1-for-15 Reverse Stock Split

Retrieved on: 
Wednesday, April 3, 2024
Common stock, Patient, Common, CUSIP, Security (finance), Therapy, Autoimmunity

Carlsbad, CA, April 03, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced a 1-for-15 reverse split of its common stock, par value $0.01 (“Common Stock”), effective at 5:00 PM ET on Friday April 5, 2024.

Key Points: 
  • Carlsbad, CA, April 03, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced a 1-for-15 reverse split of its common stock, par value $0.01 (“Common Stock”), effective at 5:00 PM ET on Friday April 5, 2024.
  • The reverse stock split was approved by Palisade Bio’s stockholders at the virtual special meeting of stockholders held on March 25, 2024.
  • As a result of the reverse stock split, every 15 shares of Common Stock issued and outstanding as of the effective date will be automatically combined into one share of Common Stock.
  • Additional information concerning the reverse stock split can be found in Palisade Bio’s definitive proxy statement filed with the Securities and Exchange Commission on February 6, 2024.

Applied UV, Inc. Announces Closing of $2.76 Million Registered Direct and Private Placement

Retrieved on: 
Monday, April 1, 2024
Common stock, Private, Exercise, Form, Telephone, Common, Sale, Attention, Share (finance), Form S-3, Prospectus, P.C, Security (finance)

The Company issued shares of common stock of the Company (“Common Stock”) and pre-funded warrants (“Pre-Funded Warrants”) in a registered direct offering.

Key Points: 
  • The Company issued shares of common stock of the Company (“Common Stock”) and pre-funded warrants (“Pre-Funded Warrants”) in a registered direct offering.
  • In a concurrent private placement, the Company also issued common warrants (“Common Warrants”) to the same investors.
  • Aggregate gross proceeds to the Company from both transactions were approximately $2.76 million.
  • The registered direct offering was being made pursuant to an effective shelf registration statement on Form S-3 (No.